Chong Kun Dang and Pfizer will co-promote 2 glaucoma treatment products
.jpg)
Chong Kun Dang is going to target the leading product market of a prostaglandin-type glaucoma treatment with Pfizer.
Chong Kun Dang(President Young-joo Kim) announced on the 16th that it established the co-marketing contract of two glaucoma eye drops with Pfizer Korea at Grand Hyatt Seoul on the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
